| James Edward Funk, SLP | |
|
820 N Chelan Ave, Wenatchee, WA 98801-2028 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | James Edward Funk |
|---|---|
| Gender | Male |
| Speciality | Speech-language Pathologist |
| Location | 820 N Chelan Ave, Wenatchee, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346275641 | NPI | - | NPPES |
| 0177341 | Other | WA | L&I |
| 8934590 | Other | WA | CRIME VICTIMS |
| 8329377 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00003122 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Edward Funk, SLP 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 | James Edward Funk, SLP 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 |
News Archive
Nearly two decades ago, Dr. Jeffrey Cadeddu was watching TV when a lightbulb went off. The program showed teens using magnetic studs to avoid piercings in their lips, and Dr. Cadeddu, a surgeon, realized the same principal could be applied to his work, reducing the number of incisions and resultant scars.
Research led by St. Jude Children's Research Hospital scientists has identified a potential target in the quest to develop a more effective treatment for leishmaniasis, a parasitic tropical disease that kills thousands and sickens more than 1 million people worldwide each year.
Brown University researchers have discovered that mefloquine, an anti-malarial drug, blocks two gap junction proteins, or connexins, in low doses and with very few side effects in the brains of laboratory mice.
According to research from the University of California, some cases of severe coronavirus disease 2019 (COVID-19) may be related to the immunological memory of previous H3N2 influenza A infection.
Forest Laboratories, Inc., a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market, announced that reported diluted earnings per share equaled $0.07 in the third quarter of fiscal 2014, compared to a reported loss per share of ($0.58) in the third quarter of fiscal 2013. The third quarter of fiscal 2014 included a $45 million charge ($28.2 million net of tax) related to Project Rejuvenate.
› Verified 2 days ago
Kevin Wayne Schell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Alexis Mary Elwood, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 S Mission St, Wenatchee, WA 98801 Phone: 509-888-2505 | |
Erica Batjer, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Tonya Lee Asmussen, MA CF SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Mrs. Elizabeth Anne Mclaughlin, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 112 Elliott Ave S, Wenatchee, WA 98801 Phone: 509-663-7117 | |
Mrs. Jean Coughlin Richtsmeier, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1111 N Mission St, Ste B, Wenatchee, WA 98801 Phone: 509-888-2505 Fax: 509-888-2507 | |
Philip Gregg, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 224 Methow St, Wenatchee, WA 98801 Phone: 509-663-5710 |